DMK Pharmaceuticals Corporation
US ˙ OTCPK ˙ US00547W3079

Introduction

This page provides a comprehensive analysis of the known insider trading history of William C Denby. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate William C Denby has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ADMP / Adamis Pharmaceuticals Corp Director 108,750
US:SNTS / Santarus, Inc Sr. VP, Commercial Operations 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by William C Denby. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases DMKPQ / DMK Pharmaceuticals Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in DMKPQ / DMK Pharmaceuticals Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2019-05-24 ADMP DENBY WILLIAM C 6,250 1.5995 89 111.9650 9,997 7 105.7 -589 -5.89
2014-09-02 ADMP DENBY WILLIAM C 2,500 5.0567 36 353.9690 12,642

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DMKPQ / DMK Pharmaceuticals Corporation Insider Trades
Insider Sales DMKPQ / DMK Pharmaceuticals Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in DMKPQ / DMK Pharmaceuticals Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DMKPQ / DMK Pharmaceuticals Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by William C Denby as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2019-05-28 2019-05-24 4 ADMP Adamis Pharmaceuticals Corp
Common Stock
P - Purchase 6,250 108,750 6.10 1.60 9,997 173,946
2019-02-01 2019-01-30 4 ADMP Adamis Pharmaceuticals Corp
Stock Option (Right to Buy)
A - Award 30,000 30,000
2018-07-11 2018-07-09 4 ADMP Adamis Pharmaceuticals Corp
Stock Option (Right to buy)
A - Award 30,000 30,000
2017-06-12 2017-06-08 4 ADMP Adamis Pharmaceuticals Corp
Stock Option (Right to buy)
A - Award 30,000 30,000
2016-05-27 2016-05-25 4 ADMP Adamis Pharmaceuticals Corp
Employee Stock Option (right to buy)
A - Award 30,000 30,000
2016-05-27 2016-05-25 4 ADMP Adamis Pharmaceuticals Corp
Common Stock
A - Award 100,000 102,500 4,000.00
2015-05-18 2015-05-15 4 ADMP Adamis Pharmaceuticals Corp
Employee Stock Option (right to buy)
A - Award 20,000 20,000
2014-11-10 2014-11-07 4 ADMP Adamis Pharmaceuticals Corp
Employee Stock Option (right to buy)
A - Award 20,000 20,000
2014-09-26 2014-09-24 4 ADMP Adamis Pharmaceuticals Corp
Employee Stock Option (right to buy)
A - Award 47,058 50,000 1,599.52
2014-09-03 2014-09-02 4 ADMP Adamis Pharmaceuticals Corp
Common Stock
P - Purchase 2,500 2,500 5.06 12,642 12,642
2014-08-27 2014-08-25 4 ADMP Adamis Pharmaceuticals Corp
Employee Stock Option (right to buy)
A - Award 2,942 2,942
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -6,792 0 -100.00 24.85 -168,781
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -58,208 6,792 -89.55
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -25,000 0 -100.00 25.62 -640,500
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -31,875 0 -100.00 25.21 -803,569
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -13,125 31,875 -29.17
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -52,364 0 -100.00 25.10 -1,314,336
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -17,636 52,364 -25.19
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -20,000 0 -100.00 29.64 -592,800
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -67,028 0 -100.00 29.64 -1,986,710
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -81,985 0 -100.00 27.37 -2,243,929
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -38,671 81,985 -32.05
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -43,684 0 -100.00 28.67 -1,252,420
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -8,641 43,684 -16.51
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -63,281 0 -100.00 28.67 -1,814,266
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -4,219 63,281 -6.25
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -62,985 0 -100.00 27.07 -1,705,004
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -4,515 62,985 -6.69
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -93,750 0 -100.00 16.58 -1,554,375
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
U - Other -30,472 0 -100.00 32.00 -975,104
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
D - Sale to Issuer -145,015 30,472 -82.64 32.00 -4,640,480 975,104
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
F - Taxes -26,695 175,487 -13.20 32.00 -854,240 5,615,584
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
A - Award 4,515 202,182 2.28 4.93 22,259 996,757
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
A - Award 4,219 197,667 2.18 3.33 14,049 658,231
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
A - Award 8,641 193,448 4.68 3.33 28,775 644,182
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
A - Award 38,671 184,807 26.46 4.63 179,047 855,656
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
A - Award 17,636 146,136 13.72 6.90 121,688 1,008,338
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
A - Award 13,125 128,500 11.38 6.79 89,119 872,515
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
A - Award 58,208 115,375 101.82 7.15 416,187 824,931
2013-11-01 2013-10-31 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -30,472 67,028 -31.25
2013-11-01 2013-10-31 4 SNTS SANTARUS INC
Common Stock
M - Exercise 30,472 57,167 114.15 2.36 71,914 134,914
2013-10-03 2013-10-01 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise X -24,450 0 -100.00
2013-10-03 2013-10-01 4 SNTS SANTARUS INC
Common Stock
S - Sale X -24,450 26,695 -47.81 23.03 -563,061 614,762
2013-10-03 2013-10-01 4 SNTS SANTARUS INC
Common Stock
M - Exercise X 24,450 51,145 91.59 1.18 28,851 60,351
2013-10-03 2013-05-14 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -26,695 85,805 -23.73
2013-10-03 2013-05-14 4 SNTS SANTARUS INC
Common Stock
M - Exercise 26,695 26,695 1.18 31,500 31,500
2013-09-04 2013-09-03 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise X -24,450 24,450 -50.00
2013-09-04 2013-09-03 4 SNTS SANTARUS INC
Common Stock
S - Sale X -24,450 0 -100.00 22.43 -548,470
2013-09-04 2013-09-03 4 SNTS SANTARUS INC
Common Stock
M - Exercise X 24,450 24,450 1.18 28,851 28,851
2013-08-02 2013-08-01 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise X -24,450 48,900 -33.33
2013-08-02 2013-08-01 4 SNTS SANTARUS INC
Common Stock
S - Sale X -24,450 0 -100.00 24.77 -605,619
2013-08-02 2013-08-01 4 SNTS SANTARUS INC
Common Stock
M - Exercise X 24,450 24,450 1.18 28,851 28,851
2013-07-02 2013-07-01 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise X -12,455 73,350 -14.52
2013-07-02 2013-07-01 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise X -12,595 0 -100.00
2013-07-02 2013-07-01 4 SNTS SANTARUS INC
Common Stock
S - Sale X -25,050 0 -100.00 21.56 -540,023
2013-07-02 2013-07-01 4 SNTS SANTARUS INC
Common Stock
M - Exercise X 12,455 25,050 98.89 1.18 14,697 29,559
2013-07-02 2013-07-01 4 SNTS SANTARUS INC
Common Stock
M - Exercise X 12,595 12,595 3.50 44,082 44,082
2013-06-04 2013-06-03 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise X -24,450 12,595 -66.00
2013-06-04 2013-06-03 4 SNTS SANTARUS INC
Common Stock
S - Sale X -24,450 0 -100.00 21.46 -524,631
2013-06-04 2013-06-03 4 SNTS SANTARUS INC
Common Stock
M - Exercise X 24,450 24,450 3.50 85,575 85,575
2013-05-02 2013-05-01 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise X -19,598 37,045 -34.60
2013-05-02 2013-05-01 4 SNTS SANTARUS INC
Common Stock
S - Sale X -24,450 0 -100.00 17.90 -437,623
2013-05-02 2013-05-01 4 SNTS SANTARUS INC
Common Stock
M - Exercise X 19,598 24,450 403.92 3.50 68,593 85,575
2013-04-02 2013-04-01 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise X -3,046 0 -100.00
2013-04-02 2013-04-01 4 SNTS SANTARUS INC
Common Stock
S - Sale X -24,450 4,852 -83.44 17.75 -433,995 86,124
2013-04-02 2013-04-01 4 SNTS SANTARUS INC
Common Stock
M - Exercise X 3,046 29,302 11.60 0.88 2,665 25,639
2013-03-12 2013-03-11 4 SNTS SANTARUS INC
Stock Options (right to buy)
A - Award 93,750 93,750
2013-03-04 2013-03-01 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise X -24,450 3,046 -88.92
2013-03-04 2013-03-01 4 SNTS SANTARUS INC
Common Stock
S - Sale X -24,450 26,256 -48.22 13.38 -327,165 351,332
2013-03-04 2013-03-01 4 SNTS SANTARUS INC
Common Stock
M - Exercise X 24,450 50,706 93.12 0.88 21,394 44,368
2013-02-04 2013-02-01 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise X -24,450 27,496 -47.07
2013-02-04 2013-02-01 4 SNTS SANTARUS INC
Common Stock
S - Sale X -24,450 26,256 -48.22 13.34 -326,187 350,281
2013-02-04 2013-02-01 4 SNTS SANTARUS INC
Common Stock
M - Exercise X 24,450 50,706 93.12 0.88 21,394 44,368
2012-03-13 2012-03-12 4 SNTS SANTARUS INC
Stock Options (right to buy)
A - Award 67,500 67,500
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)